Get Cash Back and $0 Commissions + The Power of TradeStation
Recent Analysis Shows Array BioPharma, Nabors Industries, Brinker International, Piedmont Office Realty Trust, Och-Ziff Capital Management Group, and Franklin Street Properties Market Influences Renewed Outlook, Key Drivers of Growth
Globe Newswire 4-Mar-2019 8:35 AM
NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Array BioPharma Inc. (NASDAQ:ARRY), Nabors Industries Ltd. (NYSE:NBR), Brinker International, Inc. (NYSE:EAT), Piedmont Office Realty Trust, Inc. (NYSE:PDM), Och-Ziff Capital Management Group LLC (NYSE:OZM), and Franklin Street Properties Corp. (NYSE:FSP), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Capital Review, available for free download at the links above, examine Array BioPharma Inc. (NASDAQ:ARRY), Nabors Industries Ltd. (NYSE:NBR), Brinker International, Inc. (NYSE:EAT), Piedmont Office Realty Trust, Inc. (NYSE:PDM), Och-Ziff Capital Management Group LLC (NYSE:OZM), and Franklin Street Properties Corp. (NYSE:FSP) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 28th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
ARRAY BIOPHARMA INC. (ARRY) REPORT OVERVIEW
Array BioPharma's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Array BioPharma reported revenue of $82.55MM vs $42.22MM (up 95.53%) and analysts estimated basic earnings per share -$0.05 vs -$0.17. For the twelve months ended June 30th, 2018 vs June 30th, 2017, Array BioPharma reported revenue of $173.77MM vs $150.85MM (up 15.19%) and analysts estimated basic earnings per share -$0.74 vs -$0.72. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.11. The estimated EPS forecast for the next fiscal year is -$0.44 and is expected to report on August 13th, 2019.
For the three months ended September 30th, 2018 vs September 30th, 2017, Nabors Industries reported revenue of $778.08MM vs $662.48MM (up 17.45%) and analysts estimated basic earnings per share -$0.35 vs -$0.52. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Nabors Industries reported revenue of $2,565.49MM vs $2,007.11MM (up 27.82%) and analysts estimated basic earnings per share -$1.90 vs -$3.64. Analysts expect earnings to be released on May 7th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.29. The estimated EPS forecast for the next fiscal year is -$0.17 and is expected to report on February 25th, 2020.
For the three months ended December 31st, 2018 vs December 31st, 2017, Brinker International reported revenue of $790.70MM vs $766.40MM (up 3.17%) and analysts estimated basic earnings per share $0.84 vs $0.55 (up 52.73%). For the twelve months ended June 30th, 2018 vs June 30th, 2017, Brinker International reported revenue of $3,135.42MM vs $3,150.84MM (down 0.49%) and analysts estimated basic earnings per share $2.75 vs $2.98 (down 7.72%). Analysts expect earnings to be released on May 7th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $1.08. The estimated EPS forecast for the next fiscal year is $3.99 and is expected to report on August 13th, 2019.
For the three months ended December 31st, 2018 vs December 31st, 2017, Piedmont Office Realty Trust reported revenue of $137.19MM vs $139.44MM (down 1.62%) and basic earnings per share $0.35 vs -$0.21. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Piedmont Office Realty Trust reported revenue of $525.97MM vs $574.17MM (down 8.40%) and analysts estimated basic earnings per share $1.00 vs $0.92 (up 8.70%). Analysts expect earnings to be released on May 7th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.41. The estimated EPS forecast for the next fiscal year is $1.83 and is expected to report on February 4th, 2020.
OCH-ZIFF CAPITAL MANAGEMENT GROUP LLC (OZM) REPORT OVERVIEW
Och-Ziff Capital Management Group's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Och-Ziff Capital Management Group reported revenue of $93.83MM vs $132.00MM (down 28.92%) and analysts estimated basic earnings per share -$0.80 vs $0.30. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Och-Ziff Capital Management Group reported revenue of $858.34MM vs $770.36MM (up 11.42%) and analysts estimated basic earnings per share $1.00 vs -$7.20. Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $2.70. The estimated EPS forecast for the next fiscal year is $3.55 and is expected to report on March 7th, 2019.
FRANKLIN STREET PROPERTIES CORP. (FSP) REPORT OVERVIEW
Franklin Street Properties' Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Franklin Street Properties reported revenue of $66.58MM vs $66.84MM (down 0.38%) and analysts estimated basic earnings per share $0.01 vs -$0.05. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Franklin Street Properties reported revenue of $268.87MM vs $272.59MM (down 1.36%) and analysts estimated basic earnings per share $0.12 vs -$0.15. Analysts expect earnings to be released on May 7th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.25. The estimated EPS forecast for the next fiscal year is $0.86 and is expected to report on February 11th, 2020.
Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.
REGISTERED MEMBER STATUS
Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact: Nicole Garrens, Media Department Office: +1 (410) 280-7496 E-mail: media@Capital-Review.com
